MedTrace Logo

Predictive Value of Human Microbiome and Serological Markers for Clinical Outcome of AIS With Active Cancer

NCT05553990 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-09-26

No results posted yet for this study

Summary

Explore with active cancer patients with acute ischemic stroke in the human body characteristic microorganism disorder to clinical prognosis of the predictive value of the secondary objective: to observe with active cancer patients with acute ischemic stroke in the body of microorganisms and their serological indexes change law of exploration condition change related biomarkers of microscopic objects group based on the human body.

Conditions

  • Ischemic Stroke, Acute
  • Tumor Progression

Interventions

OTHER

intestinal flora disturbance

To observe the clinical prognosis of stroke patients complicated with tumor after enterobacterial disorder

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Principal Investigators

  • JIA YIN · Nanfang Hospital, Southern Medical University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-06-07
Primary Completion
2025-04-01
Completion
2025-04-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05553990 on ClinicalTrials.gov